Litigation Settlement, Discount on Expected Payments

No definition available.

Name:	amrx_LitigationSettlementDiscountOnExpectedPayments
Namespace Prefix:	amrx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Litigation Settlement, Payment Terms

+ References

No definition available.

+ Details

Name:	amrx_LitigationSettlementPaymentTerms
Namespace Prefix:	amrx_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Litigation Settlement, Percentage Of Product Value

+ References

No definition available.

+ Details

Name:	amrx_LitigationSettlementPercentageOfProductValue
Namespace Prefix:	amrx_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

Litigation Settlement, Product Settlement

+ References

No definition available.

+ Details

Name:	amrx_LitigationSettlementProductSettlement
Namespace Prefix:	amrx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Litigation Settlement, Product Supply Amount

+ References

No definition available.

+ Details

Name:	amrx_LitigationSettlementProductSupplyAmount
Namespace Prefix:	amrx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Litigation Settlement, Product Supply Price

+ References

No definition available.

+ Details

Name:	amrx_LitigationSettlementProductSupplyPrice
Namespace Prefix:	amrx_
Data Type:	srt-types:perUnitItemType
Balance Type:	na
Period Type:	instant

- Definition

Loss Contingency, Civil Lawsuit Filed, Number Of States

+ References

No definition available.

+ Details

Name:	amrx_LossContingencyCivilLawsuitFiledNumberOfStates
Namespace Prefix:	amrx_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- Definition

Loss Contingency, Number Of Cases

+ References

No definition available.

+ Details

Name:	amrx_LossContingencyNumberOfCases
Namespace Prefix:	amrx_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- Definition

Loss Contingency, Number of Cases in Federal Courts

+ References

No definition available.

+ Details

Name:	amrx_LossContingencyNumberOfCasesInFederalCourts
Namespace Prefix:	amrx_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- Definition

Loss Contingency, Number of Cases in State Courts

+ References

No definition available.

+ Details

Name:	amrx_LossContingencyNumberOfCasesInStateCourts
Namespace Prefix:	amrx_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- Definition

Loss Contingency, Number Of Cases Settled

+ References

No definition available.

+ Details

Name:	amrx_LossContingencyNumberOfCasesSettled
Namespace Prefix:	amrx_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- Definition

Loss Contingency, Number of States Settling Claim With Free Products

+ References

No definition available.

+ Details

Name:	amrx_LossContingencyNumberOfStatesSettlingClaimWithFreeProducts
Namespace Prefix:	amrx_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- Definition

Payments For Legal Settlements, Annual Distributions, Amount

+ References

No definition available.

+ Details

Name:	amrx_PaymentsForLegalSettlementsAnnualDistributionsAmount
Namespace Prefix:	amrx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Percentage of Prescribed Label

+ References

No definition available.

+ Details

Name:	amrx_PercentageOfPrescribedLabel
Namespace Prefix:	amrx_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

The designation of funds furnished by a borrower to a lender to assure future payments of the borrower's real estate taxes and insurance obligations with respect to a mortgaged property. Escrow deposits may be made for a variety of other purposes such as earnest money and contingent payments. This element excludes replacement reserves which are an escrow separately provided for within the US GAAP taxonomy.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S45
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(10))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 954
-SubTopic 440
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478522/954-440-50-1

+ Details

Name:	us-gaap_EscrowDeposit
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.

+ References

+ Details

Name:	us-gaap_GainLossRelatedToLitigationSettlement
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Carrying amount of reserve for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid within one year of the date of the statement of financial position.

+ References

+ Details

Name:	us-gaap_LitigationReserveCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount awarded to other party in judgment or settlement of litigation.

+ References

+ Details

Name:	us-gaap_LitigationSettlementAmountAwardedToOtherParty
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(6))
-SubTopic 10
-Topic 220
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2

+ Details

Name:	us-gaap_LitigationSettlementExpense
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-9

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-4

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 405
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482645/405-30-50-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 40
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 5.W.Q2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479583/944-40-S99-1

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 275
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-9

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 720
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483359/720-20-50-1

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Topic 460
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 27
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482395/460-10-55-27

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-9

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-4

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 460
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482425/460-10-50-3

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-1

+ Details

Name:	us-gaap_LossContingenciesLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

The value (monetary amount) of the award the plaintiff seeks in the legal matter.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-1

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-9

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-4

+ Details

Name:	us-gaap_LossContingencyDamagesSoughtValue
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The total number of new claims filed pertaining to a loss contingency during the period.

+ References

+ Details

Name:	us-gaap_LossContingencyNewClaimsFiledNumber
Namespace Prefix:	us-gaap_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

The amount of cash paid for the settlement of litigation or for other legal issues during the period.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 45
-Paragraph 25
-Subparagraph (g)
-SubTopic 10
-Topic 230
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482740/230-10-45-25

+ Details

Name:	us-gaap_PaymentsForLegalSettlements
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Details

Name:	srt_StatementScenarioAxis=srt_ScenarioForecastMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_DebtInstrumentAxis=amrx_CivilPrescriptionOpioidsSettlementAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_LitigationCaseAxis=amrx_GovernmentInvestigationsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_LitigationCaseAxis=amrx_CivilPrescriptionOpioidLitigationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	amrx_LitigationSettlementOptionAxis=amrx_LitigationSettlementOptionTwoMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	amrx_LitigationSettlementOptionAxis=amrx_LitigationSettlementOptionOneMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_LitigationCaseAxis=amrx_AntitrustClassActionLitigationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_LitigationCaseAxis=amrx_UnitedStatesDepartmentOfJusticeInvestigationsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_LitigationCaseAxis=amrx_GenericDigoxinAndDoxycyclineAntitrustLitigationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_LitigationCaseAxis=amrx_RanitidineLitigationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_LitigationCaseAxis=amrx_CarickhoffV.AmnealPharmaceuticalsInc.Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Commitments and Contingencies - Narrative (Details) $ in Thousands				1 Months Ended		3 Months Ended		9 Months Ended		12 Months Ended		48 Months Ended
	Feb. 26, 2026 USD ($) case	Jan. 23, 2026 USD ($)	May 07, 2025 USD ($)	Mar. 31, 2026 USD ($) state	Apr. 30, 2024 USD ($) $ / twinPack	Sep. 30, 2026 USD ($) case state	Sep. 30, 2025 USD ($)	Sep. 30, 2026 USD ($) case state	Sep. 30, 2025 USD ($)	Dec. 31, 2020 complaint state	Dec. 31, 2019 complaint state	Dec. 31, 2034 USD ($)	Feb. 25, 2026 case	Dec. 31, 2025 USD ($)	May 15, 2023
Loss Contingencies [Line Items]
Charges (credit) related to legal matters, net						$ 6,497	$ 0	$ 15,248	$ (390)
Current portion of liabilities for legal matters						27,534		27,534						$ 43,256
Escrow deposit														24,200
Forecast
Loss Contingencies [Line Items]
Payments for legal settlements												$ 133,500
Civil Prescription Opioids Settlement Agreement
Loss Contingencies [Line Items]
Payments for legal settlements	$ 12,100	$ 23,800
Government Investigations
Loss Contingencies [Line Items]
Litigation settlement, charges						8,000		8,000
Current portion of liabilities for legal matters						8,000		8,000						0
Civil prescription opioid litigation
Loss Contingencies [Line Items]
Litigation settlement on product								21,200
Litigation settlement discount on expected payments								20,800
Current portion of liabilities for legal matters						$ 9,454		$ 9,454						42,271
Number of cases filed \| case	70												800
Number of cases filed in MDL and other federal courts \| case	24
Number of cases filed in state courts \| case	42
Litigation settlement amount				$ 11,600
Litigation settlement agreement terms					10 years
Number of states with cases \| state				5
Civil prescription opioid litigation \| Forecast
Loss Contingencies [Line Items]
Payments for legal settlements												41,400
Equal distributions, amount												$ 10,400
Civil prescription opioid litigation \| Litigation Settlement, Option Two
Loss Contingencies [Line Items]
Litigation settlement, percentage of product value				25.00%	25.00%	25.00%		25.00%
Litigation settlement amount					$ 44,400
Litigation settlement agreement terms					4 years
Civil prescription opioid litigation \| Litigation Settlement, Option One
Loss Contingencies [Line Items]
Litigation settlement amount					$ 92,500
Litigation settlement, product supply amount					$ 177,400
Litigation settlement, product supply price (in USD per twin pack) \| $ / twinPack					125
Civil prescription opioid litigation \| Litigation Settlement, Option One \| Maximum
Loss Contingencies [Line Items]
Litigation settlement amount					$ 136,900
Antitrust class action litigation
Loss Contingencies [Line Items]
Litigation settlement, charges								$ 7,500
Current portion of liabilities for legal matters						$ 7,450		$ 7,450						$ 0
United States Department of Justice Investigations
Loss Contingencies [Line Items]
Percentage of prescribed label (percent)															1.00%
Generic Digoxin and Doxycycline Antitrust Litigation
Loss Contingencies [Line Items]
Number of states, filed civil lawsuit \| state										43	43
Loss contingency, new claims filed, number \| complaint										2	2
Ranitidine Litigation
Loss Contingencies [Line Items]
Number of states with cases \| state						4		4
Number of cases \| case						95		95
Carickhoff v. Amneal Pharmaceuticals Inc., et al.
Loss Contingencies [Line Items]
Loss contingency, damages sought, value			$ 55,400